International report: Next-generation monitoring devices to use Toumaz tech Dec. 13, 2007 By John Brosky
Financings roundup: Pelikan draws in $69M for blood glucose monitoring Dec. 13, 2007 By Amanda Pedersen
FDA Panel OKs Kynapid, But Votes Against Pulzium Dec. 13, 2007 By Donna Young A panel of federal advisers told the FDA that it should approve Kynapid but reject Pulzium to treat atrial fibrillation, a condition in which the two uppermost chambers of the heart beat irregularly and at an extremely rapid rate. (BioWorld Today)Read More
RSS